Article

A Somatic Variant in MYD88 (L265P) Revealed by Whole Genome Sequencing Differentiates Lymphoplasmacytic Lymphoma From Marginal Zone Lymphomas

2011-11-18

Abstract excerpt

Abstract Abstract 261 Lymphoplasmacytic (LPL) and marginal zone lymphoma (MZL) are distinct clinicopathological entities under the WHO classification system for B-cell lymphomas. Differentiation of LPL from MZL has been difficult due to overlapping clinical, morphological, histopathological, immunophenotypic, and cytogenetic features. We therefore sought to identify a molecular marker by which LPL could be differe...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 813321f3-13b8-5070-bfab-9cc4f0f0bf1f
DOI: 10.1182/blood.v118.21.261.261

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A Somatic Variant in MYD88 (L265P) Revealed by Whole Genome Sequencing Differentiates Lymphoplasmacytic Lymphoma From Marginal Zone LymphomasDOI 10.1182/blood.v118.21.261.261Read

MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma.Semantic proximity Read

Detection of MYD88 L265P mutations in formalin-fixed and decalcified BM biopsies from patients with lymphoplasmacytic lymphoma.Semantic proximity Read

Significance of MYD88 L265P Mutation Status in the Subclassification of Low-Grade B-Cell Lymphoma/Leukemia.Semantic proximity Read

Aggressive Lymphoplasmacytic Neoplasm With an Unusual In-frame Deletion of MYD88 Associated With TRAF3 and TP53 Mutations and Complex Karyotype.Semantic proximity Read

Role of MYD88 in lymphoplasmacytic lymphoma diagnosis and pathogenesis.Semantic proximity Read

MYD88 gene and protein: molecular architecture, signalling mechanisms and clinical implications in lymphoid malignancies.Semantic proximity Read

MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma.Semantic proximity Read

Defining Lymphoplasmacytic Lymphoma: Does MYD88L265P Define a Pathologically Distinct Entity Among Patients With an IgM Paraprotein and Bone Marrow-Based Low-Grade B-Cell Lymphomas With Plasmacytic Differentiation?Semantic proximity Read

MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.Semantic proximity Read

Clinical significance of MYD88 non-L265P mutations in diffuse large B-cell lymphoma.Semantic proximity Read

Activation of TAK1 by MYD88 L265P drives malignant B-cell Growth in non-Hodgkin lymphomaSemantic proximity Read

Preneoplastic somatic mutations including MYD88L265P in lymphoplasmacytic lymphoma.Semantic proximity Read